back to top
Steven Pergam
June 21
Steven Pergam receives Resident Scholarship Mentor Award
Awards, Education, Faculty
Balloons
June 13
2024 Faculty Promotions
Faculty
Leila Armas
Andrea Campbell
Charlie Taylor
June 7
New Bias Navigators
Diversity, Education, Faculty, Staff
GEC logo
May 29
New members of the Gender Equity Council
Diversity, Faculty, Staff
Globe
May 20
Population Health Initiative awards pilot grants
Faculty, Research
Dr. Jeff Duchin
Public Health - Seattle & King County
May 14
Faculty Spotlight: Jeff Duchin
Faculty
Helen Chu
May 1
Infectious-diseases expert addresses bird flu concerns
Faculty, In the News
Dr. Helen Chu
CDC logo
April 24
Helen Chu elected to CDC advisory committee on immunization practices
Awards, Faculty
Connie Celem
Lorenzo Giacani
Roxanne Kerani
April 10
ASTDA Awards
Awards, Faculty, Research
Exceptional Women in Medicine 2024
March 21
2024 Exceptional Women in Medicine
Faculty
Adrienne Shapiro
WHO logo
March 4
The advanced HIV disease research landscape
Faculty, Research
Connie Celum
March 4
Connie Celum receives Research Excellence Award
Awards, Faculty
Meena Ramchandani
Faculty spotlight logo
February 22
Faculty spotlight: Meena Ramchandani
Clinical, Education, Faculty
Immune checkpoint inhibitors help release molecular brakes that allow cancer-killing immune cells (cyan) fight Merkel cell carcinoma (magenta). But to wage an effective seige against an MCC tumor, immune cells need fresh reinforcements. Fred Hutch and UW Medicine studies show that it's the presence of these reinforcements in a patient's blood that best predict whether checkpoint inhibitors will work for them. Image courtesy of Kimberly Smythe and Kristin Robinson / Fred Hutch Translational Pathology
February 12
New biomarker could one day help tailor immunotherapy for Merkel cell carcinoma
Faculty, Research
Tom Hawn
David Horne
January 17
Could your phone discern whether your cough is TB?
Faculty, Research